Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88103678 | FILING DATE | 09/04/2018 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | KELLY, JOHN M |
L.O. ASSIGNED | 119 |
PUB INFORMATION |
|||
RUN DATE | 12/29/2018 | ||
PUB DATE | N/A | ||
STATUS | 680-APPROVED FOR PUBLICATION | ||
STATUS DATE | 12/28/2018 | ||
LITERAL MARK ELEMENT | BICKAN | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | YES | 44D | NO | 44D | NO |
44E | NO | 44E | YES | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | BICKAN |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | OSE Immunotherapeutics |
ADDRESS | 22 Boulevard Benoni Goullin Nantes, 44200 |
ENTITY | 99-société anonyme (sa) |
CITIZENSHIP | France |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | (Based on 44(e)) (Based on Intent to Use) Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing |
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | (Based on 44(e)) (Based on Intent to Use) Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies |
INTERNATIONAL CLASS | 044 |
DESCRIPTION TEXT | (Based on 44(e)) (Based on Intent to Use) Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | SEC. 44(D) ON France |
APPLICATION NO. | 184456661 |
APPLICATION FILING DATE | 05/29/2018 |
FOREIGN REG NO. | 184456661 |
FOREIGN REG DATE | 10/26/2018 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 05/29/2028 |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
12/28/2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 011 |
12/28/2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
12/28/2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
12/27/2018 | ALIE | A | ASSIGNED TO LIE | 008 |
12/20/2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
12/15/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
12/15/2018 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
12/15/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
12/14/2018 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
09/11/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
09/07/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Patrick J. Jennings |
CORRESPONDENCE ADDRESS | PATRICK J. JENNINGS PILLSBURY WINTHROP SHAW PITTMAN, LLP 1200 SEVENTEENTH STREET, NW WASHINGTON, DC 20036 |
DOMESTIC REPRESENTATIVE | NONE |